<DOC>
	<DOC>NCT00143169</DOC>
	<brief_summary>To validate the morphine-sparing effect and safety of parecoxib administered intravenously for the treatment of Chinese subjects with postoperative pain following gynecological or orthopedic surgery.</brief_summary>
	<brief_title>Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Undergo gynecological or orthopedic surgery under epidural anesthesia A previous history of intolerance or hypersensitivity to any NSAID, cyclooxygenase2 selective inhibitors, sulphonamides, or any of the excipients of parecoxib.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>